Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
暂无分享,去创建一个
B. Nare | R. Hendrickson | P. Liberator | Y. S. Tang | R. Donald | Anita Y H Lee | Anita Y. H. Lee | J. Allocco | T. Zhong
[1] B. Nare,et al. Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase. , 2006, Molecular and biochemical parasitology.
[2] D. Schmatz,et al. Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents. , 2006, Bioorganic & medicinal chemistry letters.
[3] Michael P Barrett,et al. Chemotherapy of trypanosomiases and leishmaniasis. , 2005, Trends in parasitology.
[4] D. Schmatz,et al. Hydroxylated N-alkyl-4-piperidinyl-2,3-diarylpyrrole derivatives as potent broad-spectrum anticoccidial agents. , 2005, Bioorganic & medicinal chemistry letters.
[5] D. Schmatz,et al. Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents. , 2005, Bioorganic & medicinal chemistry letters.
[6] Andreas Gocht,et al. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. , 2005, Cellular signalling.
[7] L. Meijer,et al. Characterization of two T. gondii CK1 isoforms. , 2005, Molecular and biochemical parasitology.
[8] J. Bubis,et al. Identification of casein kinase 1, casein kinase 2, and cAMP-dependent protein kinase-like activities in Trypanosoma evansi. , 2004, Memorias do Instituto Oswaldo Cruz.
[9] D. Vetrie,et al. Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. , 2004, Molecular and biochemical parasitology.
[10] L. Sibley,et al. A role for coccidian cGMP-dependent protein kinase in motility and invasion. , 2004, International journal for parasitology.
[11] J. Bubis,et al. Protein Kinase CK1 from Trypanosoma cruzi , 2003, Journal of protein chemistry.
[12] S. Croft,et al. Leishmaniasis: new approaches to disease control , 2003, BMJ : British Medical Journal.
[13] S. Castanys,et al. Two casein kinase 1 isoforms are differentially expressed in Trypanosoma cruzi. , 2002, Molecular and biochemical parasitology.
[14] Shyam Sundar,et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. , 2002, The Lancet. Infectious diseases.
[15] C. Jaffe,et al. Effect of pH and temperature on protein kinase release by Leishmania donovani. , 2002, International journal for parasitology.
[16] B. Nare,et al. Toxoplasma gondii Cyclic GMP-Dependent Kinase: Chemotherapeutic Targeting of an Essential Parasite Protein Kinase , 2002, Eukaryotic Cell.
[17] Jeffrey Yuan,et al. Purification and Molecular Characterization of cGMP-dependent Protein Kinase from Apicomplexan Parasites , 2002, The Journal of Biological Chemistry.
[18] P. Liberator,et al. Molecular characterization of a coccidian parasite cGMP dependent protein kinase. , 2002, Molecular and biochemical parasitology.
[19] P. Liberator,et al. The role of a parasite-specific allosteric site in the distinctive activation behavior of Eimeria tenella cGMP-dependent protein kinase. , 2002, Biochemistry.
[20] J. Wilkesman,et al. Biochemical and enzymatic characterization of a partially purified casein kinase-1 like activity from Trypanosoma cruzi. , 2002, Parasitology international.
[21] B. Nare,et al. Evaluation of a Cyclic GMP-Dependent Protein Kinase Inhibitor in Treatment of Murine Toxoplasmosis: Gamma Interferon Is Required for Efficacy , 2002, Antimicrobial Agents and Chemotherapy.
[22] S. Sundar,et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] J Mottram,et al. Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. , 2000, Chemistry & biology.
[24] F. Pratlong,et al. Leishmania, Trypanosoma and Monoxenous Trypanosomatids as Emerging Opportunistic Agents1 , 2000, The Journal of eukaryotic microbiology.
[25] S. D. Gross,et al. Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. , 1998, Cellular signalling.
[26] E. A. O'neill,et al. Molecular basis for p38 protein kinase inhibitor specificity. , 1998, Biochemistry.
[27] M. Maccoss,et al. Pyrroles and other heterocycles as inhibitors of p38 kinase. , 1998, Bioorganic & medicinal chemistry letters.
[28] S H Kim,et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.
[29] Elizabeth J. Goldsmith,et al. Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding Pocket* , 1998, The Journal of Biological Chemistry.
[30] C. Jaffe,et al. Release of Ecto-protein Kinases by the Protozoan ParasiteLeishmania major* , 1997, The Journal of Biological Chemistry.
[31] D. Chakrabarti,et al. Identification, Cloning, and Mutational Analysis of the Casein Kinase 1 cDNA of the Malaria Parasite, Plasmodium falciparum , 1997, The Journal of Biological Chemistry.
[32] N. Suzuki,et al. Cultivation of bloodstream forms of Trypanosoma brucei and T. evansi in a serum‐free medium , 1997 .
[33] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[34] S. I. Becker,et al. Leishmanial protein kinases phosphorylate components of the complement system. , 1991, The EMBO journal.
[35] R. Brown,et al. Protein measurement using bicinchoninic acid: elimination of interfering substances. , 1989, Analytical biochemistry.
[36] D. Iovannisci,et al. High efficiency plating method for Leishmania promastigotes in semidefined or completely-defined medium. , 1983, The Journal of parasitology.